Fimasartan Blood Pressure Lowering After Acute Stroke (FABULOUS)

Boryung

Status: Completed

Conditions: Hypertension; Ischemic Stroke; Transient Ischemic Attack

Study type: Observational

Funder types: Industry

Identifiers

NCT03231293

BR-FMS-OS-401

Details and patient eligibility

About

This study evaluates the effectiveness of fimasartan-based antihypertensive treatment and prognosis in post-acute phase of ischemic stroke or transient ischemic attack patients. All participants will receive fimasartan, and the investigators will follow them up for 6 months.

Enrollment: 1,035 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ischemic stroke or transient ischemic attack occurs after 7 days to 3 months.
• Mean blood pressure measured 3 times at the first visit (Visit 1) should be over 140 mmHg for systolic blood pressure or 90 mmHg for diastolic blood pressure
• Suitable for administration of fimasartan
• The life expectancy should be over 6 months.

Exclusion criteria

• Patients already treated with antihypertensive medications
• Hemorrhagic stroke patients